相关实验视频
Updated: Jul 10, 2026

A High-content Assay for Monitoring AMPA Receptor Trafficking
Published on: January 28, 2019
TARP辅助子单元将AMPA受体对抗剂切换为部分激动剂
Karen Menuz1, Robert M Stroud, Roger A Nicoll
1Department of Cellular and Molecular Pharmacology, University of California at San Francisco, San Francisco, CA 94143, USA.
常见的AMPA受体对抗剂CNQX在存在跨膜AMPA受体调节蛋白 (TARP) 时起作用为部分激动剂. 美国TARP提高了CNQX.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 昆素二化合物,如6--7-尼特诺素-2,3- (CNQX),被广泛用作α-氨基-3-基-5-甲基-4-异醇酸 (AMPA) 受体对抗剂.
- 跨膜AMPA受体调节蛋白 (TARP) 是调节AMPA受体功能的关键辅助子单元.
研究的目的:
- 研究TARPs在调节AMPA受体中CNQX活性方面的功能作用.
- 阐明TARPs影响CNQX激动剂/对抗剂性质的机制.
主要方法:
- 中枢神经系统神经元中的电生理记录,以测量CNQX诱导的电流.
- 涉及AMPA受体和TARP的同表达研究.
- 结晶结构分析CNQX与没有TARP的AMPA受体连接体结合域结合.
主要成果:
- CNQX在神经元中诱导了小的去极化电流,表明在TARPs存在时的部分激素活性.
- 这种激素活性取决于TARPs的共同表达.
- 晶体结构显示,虽然在没有TARP的情况下,CNQX会导致部分域关闭,但这不会转化为通道开放,这表明TARP会加强这种合.
结论:
- AMPA受体辅助子单元 (TARP) 的存在可以从根本上改变化合物的药理特征,将其从对抗剂转变为部分激动剂.
- 在提高部分激动剂的疗效方面,TARP发挥着至关重要的作用,因为它通过改善连接体与通道关结合的转导来提高部分激动剂的疗效.
更多相关视频
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
相关概念视频
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Desensitization and Tachyphylaxis
Several...
GPCR Desensitization
Opioid Receptors: Overview